A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

8.1K views

⸱

DOI:

10.3791/51915

⸱

November 14th, 2014

In This Article

Summary

Botulinum neurotoxin is one of the most potent toxins among Category-A biothreat agents, yet a post-exposure therapeutic is not available. The high content imaging approach is a powerful methodology for identifying novel inhibitors as it enables multiparameter screening using biologically relevant motor neurons, the primary target of this toxin.

Abstract

Synaptosomal-associated protein-25 (SNAP-25) is a component of the soluble NSF attachment protein receptor (SNARE) complex that is essential for synaptic neurotransmitter release. Botulinum neurotoxin serotype A (BoNT/A) is a zinc metalloprotease that blocks exocytosis of neurotransmitter by cleaving the SNAP-25 component of the SNARE complex. Currently there are no licensed medicines to treat BoNT/A poisoning after internalization of the toxin by motor neurons. The development of effective therapeutic measures to counter BoNT/A intoxication has been limited, due in part to the lack of robust high-throughput assays for screening small molecule libraries. Here we describe a high content imaging (HCI) assay with utility for identification of BoNT/A inhibitors. Initial optimization efforts focused on improving the reproducibility of inter-plate results across multiple, independent experiments. Automation of immunostaining, image acquisition, and image analysis were found to increase assay consistency and minimize variability while enabling the multiparameter evaluation of experimental compounds in a murine motor neuron system.

Introduction

The bacterium Clostridium botulinum produces Botulinum neurotoxin, one of the most potent biological toxins known to man1. There are 7 distinct BoNT serotypes (BoNT/A-G). BoNT/A-Gall induce paralysis at the neuromuscular junction due to SNARE complex proteolysis 2,3. SNARE proteolysis prevents neurotransmitter vesicle-membrane fusion and therefore blocks neurotransmitter exocytosis4. The specific SNARE target depends upon the particular BoNT serotype involved in the intoxication process. BoNT/A and BoNT/E cleave SNAP-25 whereas BoNT/C cleaves both SNAP-25 and syntaxin5. The remaining serotypes cleave synaptobrevin (....

Access restricted. Please log in or start a trial to view this content.

Protocol

Plate 20,000 differentiated mouse ES cells (MES) / well in a 96 well Poly-D lysine coated plates and maintain in motor neuron terminal differentiation media for 5-7 days.

1. Compound Administration and Intoxication with BoNT/A

Perform all of the following work in a BSL2 enclosure to maintain compliance with CDC/NIH guidelines.

  1. Prepare 10 mM stock solutions of each library compound in 100% DMSO in polypropylene 96 well plates. Use the 10 mM stock to prepare an intermediate dilution plate that is 10-fold greater than the desired screening concentration. Prepare 100 uM intermediate plate by dispensing 10....

Access restricted. Please log in or start a trial to view this content.

Results

Data from high and low controls created two distinct populations with the difference of two medians exceeding 3 standard deviations (Figure 7A). The goal of the screening process is to find the compounds within the sample population with values closer to positive control population, assuming a normal distribution within the sample population (Figure 7B, (i)). Data points that are 3 standard deviations beyond the mean are considered statistically different from the noise and classified as.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The high potency of Botulinum neurotoxins and the relative ease of their weaponization has resulted in their classification as Category A (highest priority) biothreat agents by the U.S. Centers for Disease Control and Prevention. Unfortunately, there are no FDA approved therapeutics to counter BoNT intoxication after the toxin has been internalized by the motor neurons. Any druggable mechanism that promotes neuronal recovery from BoNT intoxication could lead toward the development of a potential therapy to protect both t.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Krishna P Kota is an employee of Perkin Elmer Inc. Waltham, MA, that produces instruments and software used in this manuscript. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, the U.S. Department of Defense, the U.S. Department of the Army, or the institutions and companies affiliated with the authors.

Acknowledgements

Funding was provided by the Joint Science and Technology Office – Chemical Biological Defense (JSTO-CBD) Defense Threat Reduction Agency (DTRA) under sponsor project number CCAR# CB3675 and National Institutes of Health (1 R21 AI101387-01 and 5 U01AI082051-05).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Botulinum neurotoxin A MetabiologicsNANo catalog number
Microtitre platesGreiner 655946Poly-D-Lysine 96-well plates
BACs antibodyLampire BiologicalNA
MicrochemNational 0255
MethanolThermo ScientificA412-20
FormaldehydeThermo Scientific28908
Horse serumInvitrogen16050
PE JANUS MDT Mini Automated WorkstationPerkin ElmerAJMDT01
OperaPerkin ElmerOP-QEHS-01
Triton X-100Sigma-Aldrich9002-93-1
BIII tubulin antibodyR&D SystemsBAM1195
Tween 20SigmaP1379-1L
Hoechst 33342dye Invitrogen3570
Antimouse IgGInvitrogenA21236
Anti rabbit IgGInvitrogenA10042
Columbus Image analysis softwarePerkin ElmerVer 2.4
SpotfirePerkin ElmerVer 5.5
Clorox bleachFisher Scientific18-861-284
PlateStack

References

  1. Lamanna, C. The most poisonous poison. Science. 130, 763-772 (1959).
  2. Dover, N., Barash, J. R., Hill, K. K., Xie, G., Arnon, S. S. Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene. J. Infect. Dis. , (2013).
  3. Hakami, R. M., Ruthel, G., Stahl, A. M., Bavari, S.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

SNAP-25 CleavageMouse Motor NeuronsImmunostaining AutomationImage Analysis SoftwarePhenotypic Screening AssayNeurotransmitter ReleaseToxin Uptake PreventionMetalloprotease Activity